The Importance of Testing PET-Directed Therapy in Patients with Hodgkin Lymphoma

详细信息    查看全文

• 作者：James O. Armitage (1)
  
• 刊名：Current Hematologic Malignancy Reports
• 出版年：2011
• 出版时间：September 2011
• 年：2011
• 卷：6
• 期：3
• 页码：155-156
• 全文大小：117KB
• 参考文献：1. Peters MV, Middlemiss KC. A study of Hodgkin鈥檚 disease treated by irradiation. Am J Roentgenol Radium Ther Nucl Med. 1958;79(1):114鈥?1.
  2. Kaplan HS. The radical radiotherapy of regionally localized Hodgkin鈥檚 disease. Radiology. 1962;78:553鈥?1.
  3. DeVita Jr VT, Serpick AA, Carbone PP. Combination chemotherapy in the treatment of advanced Hodgkin鈥檚 disease. Ann Intern Med. 1970;73(6):881鈥?5.
  4. Armitage JO. Early-stage Hodgkin鈥檚 lymphoma. N Engl J Med. 2010;363(7):653鈥?2. CrossRef
  5. Sher DJ, Mauch PM, Van Den Abbeele A, LaCasce AS, Czerminski J, Ng AK. Prognostic significance of mid- and post-ABVD PET imaging in Hodgkin鈥檚 lymphoma: the importance of involved-field radiotherapy. Ann Oncol. 2009;20(11):1848鈥?3. CrossRef
  6. Barnes J, LaCasce A, Toomey C, et al. Early interim FDG-PET scan predicts outcome in non-bulky limited stage Hodgkin lymphoma, but may not guide use of consolidative radiotherapy [abstract]. Blood. 2008;112:518.
  
• 作者单位：James O. Armitage (1)
  
  1. The Joe Shapiro Professor of Medicine, Department of Internal Medicine, University of Nebraska Medical Center, 987680 Nebraska Medical Center, Omaha, NE, 68198-7680, USA
  

文摘

Measuring the rapidity of response by PET scan and changing the treatment regimen in slow responders may lead to an improved outcome. Ongoing studies addressing this possibility have the potential to answer this question and need to be supported.